Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma

Clinical Trial ID NCT00381797

PubWeight™ 6.34^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00381797

Top papers